Navigation Links
PSA Test's Overall Benefit Still Unclear: Study
Date:8/15/2012

By Maureen Salamon
HealthDay Reporter

WEDNESDAY, Aug. 15 (HealthDay News) -- The latest entry in the scientific debate over the value of prostate-specific antigen (PSA) testing suggests its overall worth remains far from clear.

Using statistical modeling, Dutch researchers concluded its benefits are diminished by lost quality of life from serious side effects and the decision whether to screen should be left to men and their doctors.

In their study, the study author predicted that annual PSA tests for men aged 55 to 69 would result in nine fewer prostate cancer deaths (28 percent) for every 1,000 men screened.

But they were also able to quantify harm and survival on the same scale by calculating quality-adjusted life years.

With harms such as impotence and incontinence factored in, "the disadvantages of screening diminish the benefits [of added lifespan] by 20 percent," said study author Eveline Heijnsdijk, a researcher at the department of public health of Erasmus Medical Center in Rotterdam.

"Individuals and clinicians have to decide themselves whether the benefits outweigh the harms," Heijnsdijk said.

The quality-adjusted life year index is a measure that assesses the value of a medical intervention. PSA is a protein in cells of the prostate gland, and the higher a man's PSA the more likely it is he has cancer.

Dr. Louis Potters, chair of radiation medicine at North Shore-LIJ Health System in New Hyde Park, N.Y., agreed the findings suggest a need to consider each case individually.

"Once again, these results confound any definitive conclusion," said Potters. "This particular study further hardens the argument that you do need to think about it, you do need to personalize it and there isn't a one-size-fits-all approach, as disappointing as it might be for each side of the argument."

The study is published Aug. 16 in the New England Journal of Medicine.

In May, the U.S. Preventive Services Task Force recommended against routine PSA screening, saying too many non-dangerous cancers were being treated aggressively and resulting in unnecessary harm.

But a July study in the journal Cancer found that not screening American men would triple the number developing advanced cancer, and the American Society of Clinical Oncology recommended that men with a life expectancy of more than 10 years talk with their doctors about getting the test.

This new analysis uses information gleaned from the European Randomized Study of Screening for Prostate Cancer, which evaluated the effect of PSA screening on prostate cancer mortality in 162,000 men in seven countries.

The scientists confirmed that PSA screening would save lives, and using a quality-adjusted life year index they concluded that 73 total life-years would be gained for every 1,000 men screened. However, only 56 of the 73 life-years gained would be considered "quality" years once adjusted for adverse effects related to overdiagnosis and treatment of cancers that would never turn lethal.

Potters asserted that the argument whether or not to screen would "go away" if more patients underwent surveillance of their prostate cancer rather than active treatments such as prostate removal or radiation -- therapies the study noted leave between 42 percent and 88 percent of men impotent.

Between 40 percent and 48 percent of men diagnosed with prostate cancer are eligible for surveillance, which closely monitors their cancer, he said.

"That's the opportunity that's sort of lacking," he added. "We're getting blinded by the argument of screening when I think the argument is really over treatment."

More information

The U.S. National Cancer Institute offers a fact sheet about PSA testing.

SOURCES: Eveline Heijnsdijk, Ph.D., researcher, department of public health, Erasmus Medical Center, Rotterdam, the Netherlands; Louis Potters, M.D., chair, radiation medicine, North Shore-LIJ Health System, New Hyde Park, N.Y.; Aug. 16, 2012, New England Journal of Medicine


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Imaging Tests Up Among Advanced Cancer Patients
2. A new genre of diagnostic tests for the era of personalized medicine
3. Many Teens With High Blood Pressure Dont Get Needed Tests
4. HIV suppression not as good as previously thought, largest study of viral-load blood tests show
5. Every 3 Years Is Best for Stomach Cancer Tests: Study
6. 40,000 Arizona student athletes receive concussion tests from Mayo Clinic
7. 2 new vitamin D blood tests are often highly inaccurate, researchers say
8. Super-sensitive tests could detect diseases earlier
9. Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy
10. U.S. Advisers Say No to Routine PSA Tests for Prostate Cancer
11. Better tests for sleeping sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 10, 2016 , ... Intermedix announced on Wednesday that it ... emergency medicine professional association, to support the organization's newly established physician group with ... Emergency Medicine, or AAEM, seeks to empower emergency physicians to control their own ...
(Date:2/10/2016)... ... February 10, 2016 , ... The Wickman Agency ... to assist the local community. Pledging to select a new beneficiary every 60 ... the area. Their goal is to bring community awareness to important local causes ...
(Date:2/10/2016)... ... February 10, 2016 , ... 10 Best Water is excited ... bottled water brand owners that topped the list as a result of their commitment ... The premier brand was Tibet 5100, a top notch water company that specializes in ...
(Date:2/10/2016)... ... 10, 2016 , ... Dr. Jessica Barron, of Barron Family Dental in ... patients and families in the North Metro Denver area. The new dental practice focuses ... dentistry, and all in the most relaxing environment. , While some dental visits can ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... bring together more than 200 of the country’s top healthcare executives to share ... “The true benefit of the Forum is the provider-centric perspective, experience, expertise and ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Inc. (Vanda) (NASDAQ: VNDA ), today announced financial ... year ended December 31, 2015. --> ... for Vanda with the continued growth of HETLIOZ in ... for Non-24," said Mihael H. Polymeropoulos, M.D., Vanda,s President ... product portfolio builds on this success and underscores Vanda,s ...
(Date:2/10/2016)... new report from business intelligence provider GBI Research - Alzheimer,s Disease Therapeutics ... than double from just under $5 billion in 2014 to an estimated $10.4 ... Canada , France , Germany ... UK, and Japan , and will primarily be driven by ... , France , Germany , ...
(Date:2/10/2016)...  CVS Health (NYSE: CVS ) is offering ... Santa Clara County, CA , in response to ... University campus. CVS Pharmacy stores and MinuteClinic walk-in medical ... disease. Students at Santa Clara University who have not ... anyone who has had close contact with a person ...
Breaking Medicine Technology: